Abstracts & Poster Presentations
We’re glad to welcome trainees in the field of theranostics and radiopharmaceuticals to the Leaders’ Summit 2025 as part of our Call for Abstracts. The successful candidates are listed below along with the details of their research.
Thursday June 12
Colin Belliveau
12:30-12:40 PM
University of Montreal
Adaptive External Beam and Radioligand Radiotherapy for MEtaSTatic castration resistant prostate cancer (ARREST) : a phase II registry-based RCT
Mark Macsuka
12:40-12:50 PM
University of Oxford
Cyclic Changes of Absorbed Dose as a Biomarker for Radiological Response in Neuroendocrine Tumours Treated with [177Lu]Lu-DOTATATE
Ibrahim Alrekhais
12:50-1:00 PM
UHN
Scott McNeil
3:05-3:15 PM
TRIUMF (UBC)
Cyclotron Production of Tb-155
Chloe Green
3:15-3:25 PM
McMaster University
Optimization of Technetium-94m Production by Cyclotron Proton Irradiation of Phosphomolybdic Acid using an Automated Liquid Target System
Itzel Astiazarán-Rascón
5:30-5:40 PM
BC Cancer Research Centre/UBC
Joshua Mojica
5:40-5:50 PM
Simon Fraser University
Dominic Simpson
5:50-6:00 PM
Centre for Addiction and Mental Health (CAMH)
Examination of neuroinflammation in multiple sclerosis mouse models via quantification of cyclooxygenase-1 (COX-1) with the PET radioligand, [¹¹C]PS13.
Friday June 13
Michael Valic
10:30-10:40 PM
UHN/ University of Toronto
Desiree Fiaccabrino
10:40-10:50 PM
On behalf of the Leaders’ Summit Executive Planning Committee, thank you to poster walk professors Dr. Glenn Bauman, London Health Sciences; Dr. David Green, University Health Network; Dr. Cynthia Menard, CHUM; and Dr. Raymond Reilly, University of Toronto.